These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25009495)

  • 21. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.
    Harkany T; Hortobágyi T; Sasvári M; Kónya C; Penke B; Luiten PG; Nyakas C
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):963-1008. PubMed ID: 10621945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc and its effects on oxidative stress in Alzheimer's disease.
    Yuan Y; Niu F; Liu Y; Lu N
    Neurol Sci; 2014 Jun; 35(6):923-8. PubMed ID: 24522515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Brain zinc dyshomeostasis and glial cells in ischemic stroke].
    Higashi Y; Aratake T; Shimizu S; Shimizu T; Saito M
    Nihon Yakurigaku Zasshi; 2019; 154(3):138-142. PubMed ID: 31527364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ageing and Cognition.
    Juan SMA; Adlard PA
    Subcell Biochem; 2019; 91():107-122. PubMed ID: 30888651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Vulnerability of the Dentate Gyrus to Aging and Amyloid-β
    Takeda A; Tamano H
    Biol Pharm Bull; 2018; 41(7):995-1000. PubMed ID: 29962410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The decreased astrocyte-microglia interaction reflects the early characteristics of Alzheimer's disease.
    Liu K; Aierken A; Liu M; Parhat N; Kong W; Yin X; Liu G; Yu D; Hong J; Ni J; Quan Z; Liu X; Ji S; Mao J; Peng W; Chen C; Yan Y; Qing H
    iScience; 2024 Mar; 27(3):109281. PubMed ID: 38455972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of Alzheimer's disease drugs and their relationship with neuron-glia interaction.
    Ajenikoko MK; Ajagbe AO; Onigbinde OA; Okesina AA; Tijani AA
    IBRO Neurosci Rep; 2023 Jun; 14():64-76. PubMed ID: 36593897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.
    Morton H; Kshirsagar S; Orlov E; Bunquin LE; Sawant N; Boleng L; George M; Basu T; Ramasubramanian B; Pradeepkiran JA; Kumar S; Vijayan M; Reddy AP; Reddy PH
    Free Radic Biol Med; 2021 Aug; 172():652-667. PubMed ID: 34246776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
    Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
    J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SUMO and Alzheimer's disease.
    Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
    Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors.
    Durand D; Carniglia L; Turati J; Ramírez D; Saba J; Caruso C; Lasaga M
    Neuropharmacology; 2017 Sep; 123():274-286. PubMed ID: 28495373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuron-glia interactions as therapeutic targets in neurodegeneration.
    Salmina AB
    J Alzheimers Dis; 2009; 16(3):485-502. PubMed ID: 19276541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease, beta-amyloid protein and zinc.
    Huang X; Cuajungco MP; Atwood CS; Moir RD; Tanzi RE; Bush AI
    J Nutr; 2000 May; 130(5S Suppl):1488S-92S. PubMed ID: 10801964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals.
    Zhang L; Xia R; Jia J; Wang L; Li K; Li Y; Zhang J
    Mol Immunol; 2018 Jul; 99():95-103. PubMed ID: 29747052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron-astrocyte signaling is preserved in the aging brain.
    Gómez-Gonzalo M; Martin-Fernandez M; Martínez-Murillo R; Mederos S; Hernández-Vivanco A; Jamison S; Fernandez AP; Serrano J; Calero P; Futch HS; Corpas R; Sanfeliu C; Perea G; Araque A
    Glia; 2017 Apr; 65(4):569-580. PubMed ID: 28130845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Picomolar amyloid-β peptides enhance spontaneous astrocyte calcium transients.
    Lee L; Kosuri P; Arancio O
    J Alzheimers Dis; 2014; 38(1):49-62. PubMed ID: 23948929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid β attenuates metabotropic zinc sensing receptor, mZnR/GPR39, dependent Ca
    Abramovitch-Dahan C; Asraf H; Bogdanovic M; Sekler I; Bush AI; Hershfinkel M
    J Neurochem; 2016 Oct; 139(2):221-233. PubMed ID: 27501363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.